Leptin-stimulated endothelial nitric-oxide synthase via an adenosine 5′-monophosphate-activated protein kinase/Akt signaling pathway is attenuated by interaction with C-reactive protein

Endocrinology

Volumn 150, Issue 8, 2009, Pages 3584-3593

  Procopio, Cristina ^a   Andreozzi, Francesco ^a   Laratta, Emanuela ^a   Cassese, Angela ^b   Beguinot, Francesco ^b   Arturi, Franco ^a   Hribal, Marta Letizia ^a   Perticone, Francesco ^a   Sesti, Giorgio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LEPTIN; PROTEIN KINASE B; SERINE; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; C-REACTIVE PROTEIN; CELL LINE; CYCLIC GMP; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LEPTIN; MICE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 67651162132     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0921     Document Type: Article

References (51)

1. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM 2004 Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291:2847-2850
2. Hossain P, Kawar B, El Nahas M 2007 Obesity and diabetes in the developing world: a growing challenge. N Engl J Med 356:213-215
3. Eckel RH, Krauss RM 1998 American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation 97:2099-2100
4. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB 2002 Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 162:1867-1872
5. Friedman JM, Halaas JL 1998 Leptin and the regulation of body weight in mammals. Nature 395:763-770
6. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM 1995 Leptin levels inhuman and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1:1155-1161
7. Sierra-Honigmann MR, Nath AK, Murakami C, García-Cardeña G, Papapetropoulos A, Sessa WC, Madge LA, Schechner JS, Schwabb MB, Polverini PJ, Flores-Riveros JR 1998 Biological action of leptin as an angiogenic factor. Science 281:1683-1686
8. Bełtowski J, Wójcicka G, Jamroz-Wiœniewska A 2006 Role of nitric oxide and endothelium-derived hyperpolarizing factor (EDHF) in the regulation of blood pressure by leptin in lean and obese rats. Life Sci 79:63-71
9. Frühbeck G 1999 Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes 48:903-908
10. Lembo G, Vecchione C, Fratta L, Marino G, Trimarco V, d'Amati G, Trimarco B 2000 Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes 49:293-297
11. Kimura K, Tsuda K, Baba A, Kawabe T, Boh-oka S, Ibata M, Moriwaki C, Hano T, Nishio I 2000 Involvement of nitric oxide in endothelium-dependent arterial relaxation by leptin. Biochem Biophys Res Commun 273:745-749
12. Beltowski J, Wójcicka G, Borkowska E 2002 Human leptin stimulates systemic nitric oxide production in the rat. Obes Res 10:939-946
13. ob) mice. J Appl Physiol 89:2382-2390
14. Vecchione C, Maffei A, Colella S, Aretini A, Poulet R, Frati G, Gentile MT, Fratta L, Trimarco V, Trimarco B, Lembo G 2002 Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes 51:168-173
15. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC 1999 Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399:597-601
16. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM 1999 Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399:601-605
17. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Müller C, Carling D, Kahn BB 2002 Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415:339-343
18. Hardie DG 2004 The AMP-activated protein kinase pathway: new players upstream and downstream. J Cell Sci 117:5479-5487
19. Carling D 2004 The AMP-activated protein kinase cascade: a unifying system for energy control. Trends Biochem Sci 29:18-24
20. Merrill GF, Kurth EJ, Hardie DG, Winder WW 1997 AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol 273:E1107-E1112
21. Kurth-Kraczek EJ, Hirshman MF, Goodyear LJ, Winder WW 1999 5′ AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 48:1667-1671
22. Bergeron R, Ren JM, Cadman KS, Moore IK, Perret P, Pypaert M, Young LH, Semenkovich CF, Shulman GI 2001 Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am J Physiol Endocrinol Metab 281:E1340-E1346
23. Winder WW, Hardie DG 1996 Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am J Physiol 270:E299-E304
24. Chen ZP, Mitchelhill KI, Michell BJ, Stapleton D, Rodriguez-Crespo I, Witters LA, Power DA, Ortiz de Montellano PR, Kemp BE 1999 AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 443:285-289
25. Davis BJ, Xie Z, Viollet B, Zou MH 2006 Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. Diabetes 55:496-505
26. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ 2003 Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 278:45021-45026
27. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T, Funahashi T, Walsh K 2004 Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 279:1304-1309
28. Thors B, Halldórsson H, Thorgeirsson G 2004 Thrombin and histamine stimulate endothelial nitric-oxide synthase phosphorylation at Ser1177 via an AMPK mediated pathway independent of PI3K-Akt. FEBS Lett 573:175-180
29. Levine YC, Li GK, Michel T 2007 Agonist-modulated regulation of AMP-activated protein kinase (AMPK) in endothelial cells. Evidence for an AMPK→Rac→Akt→endothelial nitric-oxide synthase pathway. J Biol Chem 282:20351-20364
30. Nagata D, Mogi M, Walsh K 2003 AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress. J Biol Chem 278:31000-31006
31. Morrow VA, Foufelle F, Connell JM, Petrie JR, Gould GW, Salt IP 2003 Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells. J Biol Chem 278:31629-31639
32. Chen K, Li F, Li J, Cai H, Strom S, Bisello A, Kelley DE, Friedman-Einat M, Skibinski GA, McCrory MA, Szalai AJ, Zhao AZ 2006 Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nat Med 12:425-432
33. Farooqi IS, O'Rahilly S 2007 Is leptin an important physiological regulator of CRP? Nat Med 13:16-17; author reply 19-21
34. Hutchinson WL, Coll AP, Gallimore JR, Tennent GA, Pepys MB 2007 Is leptin an important physiological regulator of CRP? Nat Med 13:17-18; author reply 19-21
35. Gertler A, Niv-Spector L, Reicher S 2007 Is leptin an important physiological regulator of CRP? Nat Med 13:18-19; author reply 19-21
36. Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV, Dhillon B, Weisel RD, Li RK, Mickle DA, Stewart DJ 2002 A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 106:913-919
37. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB 1999 Elevated C-reactive protein levels in overweight and obese adults. JAMA 282:2131-2135
38. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH 1997 Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973-979
39. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V 2004 C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387-1397
40. D'Alessandris C, Lauro R, Presta I, Sesti G 2007 C-reactive protein induces phosphorylation of insulin receptor substrate-1 on Ser307 and Ser612 in L6 myocytes, thereby impairing the insulin signalling pathway that promotes glucose transport. Diabetologia 50:840-849
41. 616 in human umbilical vein endothelial cells. Circ Res 94:1211-1218
42. Andreozzi F, Laratta E, Procopio C, Hribal ML, Sciacqua A, Perticone M, Miele C, Perticone F, Sesti G 2007 Interleukin-6 impairs the insulin signaling pathway promoting production of nitric oxide in human umbilical vein endothelial cells. Mol Cell Biol 27:2372-2383
43. Chen J, Somanath PR, Razorenova O, Chen WS, Hay N, Bornstein P, Byzova TV 2005 Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nat Med 11:1188-1196
44. Somanath PR, Razorenova OV, Chen J, Byzova TV 2006 Akt1 in endothelial cell and angiogenesis. Cell Cycle 5:512-518
45. Xu JW, Morita I, Ikeda K, Miki T, Yamori Y 2007 C-reactive protein suppresses insulin signaling in endothelial cells: role of spleen tyrosine kinase. Mol Endocrinol 21:564-573
46. Goirand F, Solar M, Athea Y, Viollet B, Mateo P, Fortin D, Leclerc J, Hoerter J, Ventura-Clapier R, Garnier A 2007 Activation of AMP kinase α1 subunit induces aortic vasorelaxation in mice. J Physiol 581:1163-1171
47. Horman S, Vertommen D, Heath R, Neumann D, Mouton V, Woods A, Schlattner U, Wallimann T, Carling D, Hue L, Rider MHJ 2006 Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase α-subunits in heart via hierarchical phosphorylation of Ser485/491. J Biol Chem 281:5335-5340
48. Kovacic S, Soltys CL, Barr AJ, Shiojima I, Walsh K, Dyck JRB 2003 Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart. J Biol Chem 278:39422-39427
49. Festa A, D'Agostino Jr R, Howard G, Mykkänen L, Tracey RP, Haffner SM 2000 Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102: 42-47
50. Ford ES 1999 Body mass index, diabetes, and C-reactive protein among US adults. Diabetes Care 22:1971-1977
51. Schulze MB, Rimm EB, Li T, Rifai N, Stampfer MJ, Hu FB 2004 C-reactive protein and incident cardiovascular events among men with diabetes. Diabetes Care 27:889-894